Overcome Addiction with the Help of Inpatient Kirkbride Center in Philadelphia, PA

Discover holistic care and support at The Kirkbride Center, a licensed 302-bed behavioral health facility on a serene 17-acre campus in Philadelphia's vibrant University City neighborhood. With a comprehensive range of addiction services, we're dedicated to guiding you toward lasting recovery and wellness. The Kirkbride Center maintains accreditation with the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO). It holds special certification from the Joint Commission, PA Department of Drug and Alcohol Program for Medication Assisted Treatment, and all requisite state and federal licenses. Our facility accepts a wide range of insurance plans, including Medicaid, Magellan, CBH, and BHSI patients, ensuring accessibility to quality care for all.

As per local authorities, fentanyl, a potent synthetic opioid, stands as the primary local drug threat in the Philadelphia area. Data from the Philadelphia Department of Public Health for the year 2022 reveals a staggering total of 1,413 overdose deaths in the city. Alarmingly, 80% of these fatalities involved the presence of fentanyl. [1] This formidable substance has been detected not only in opioids but also in cocaine, methamphetamine, counterfeit pills, and various other illicit substances. Fentanyl is similar to morphine but is estimated to be about 50 to 100 times more potent. 

Kirkbride has been at the forefront of opiate addiction treatment since 2000, offering a comprehensive array of pharmacotherapies tailored to each individual's clinical needs. Our services include methadone maintenance, buprenorphine (Suboxone), and naltrexone (Vivitrol) in both oral and extended-release formulations. These medications are utilized for detoxification as well as maintenance to alleviate withdrawal symptoms. As pioneers in the greater Philadelphia area, we were the first inpatient program licensed by the state to administer Suboxone maintenance. We prioritize collaboration with reputable outpatient programs to seamlessly continue Suboxone maintenance, with established referral agreements in Philadelphia, Delaware, and Bucks counties. If you're seeking drug treatment centers in Philadelphia, finding a rehabilitation facility like Kirkbride Center is essential for individuals pursuing effective and professional addiction treatment.

Is this facility considered a psychiatric rehab hospital?

Kirkbride Center is considered a behavioral health care facility that provides comprehensive services for individuals struggling with addiction and mental health disorders. Our facility offers medication-assisted treatment options. Moreover, we provide evidence-based therapies such as cognitive-behavioral therapy (CBT), group therapy, and trauma-informed care to support holistic recovery. Our multidisciplinary team of professionals is dedicated to providing comprehensive care and support to help individuals achieve lasting wellness. With a focus on individualized treatment plans and compassionate support, Kirkbride Center strives to empower individuals on their journey to recovery and improved mental health.

Cognitive behavioral therapy (CBT) has proven effective in treating substance use disorders, both as a standalone therapy and in combination with other treatment approaches. [2] Its success stems from its ability to address the underlying thought patterns and behaviors associated with addiction. By helping individuals recognize and modify negative thought patterns and develop healthier coping skills, CBT equips them with the tools needed to overcome addiction and maintain sobriety. Also, CBT's emphasis on addressing co-occurring mental health issues, such as anxiety and depression, makes it particularly effective for individuals facing dual diagnosis.

Does this facility offer inpatient rehab services?

Kirkbride Center offers inpatient rehabilitation services as part of its comprehensive behavioral health care programs. Our addiction services also include:

• Detoxification: Detox is the process of removing toxins, primarily drugs or alcohol, from the body. It is typically the first step in addiction treatment and is aimed at managing withdrawal symptoms in a safe and supervised environment. Medical professionals may administer medications to alleviate discomfort and ensure the individual's safety throughout detox.
• Drug-free residential rehabilitation: It is also known as inpatient rehabilitation and involves staying in a specialized facility where individuals receive intensive treatment and support for their addiction. This comprehensive program typically includes individual and group therapy, educational sessions, and life skills training to help individuals overcome their addiction and develop coping mechanisms for long-term sobriety. Unlike medication-assisted treatment, drug-free residential rehabilitation does not involve the use of medications to manage cravings or withdrawal symptoms.
• Methadone treatment: Methadone is a long-acting opioid agonist that helps to reduce cravings and opioid withdrawal symptoms, allowing individuals to stabilize their lives and participate in treatment and other activities. Methadone treatment is typically administered under the supervision of a healthcare provider in a specialized clinic and is often combined with counseling and other supportive services.
• Suboxone treatment: Suboxone treatment is another form of medication-assisted treatment for opioid addiction. Suboxone contains a combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. This combination helps to reduce cravings and withdrawal symptoms while also deterring misuse. Suboxone treatment is typically provided in outpatient settings and is often combined with counseling and behavioral therapy to support recovery.
• Vivitrol treatment: Vivitrol is an extended-release formulation of naltrexone, an opioid antagonist that blocks the effects of opioids and reduces alcohol cravings. Vivitrol is administered via injection once a month and is often used as part of a comprehensive treatment plan that includes counseling and support services.

Each of these treatment options is crucial in addressing addiction and supporting individuals on their journey to recovery. Individuals must work with healthcare professionals to determine the most appropriate treatment approach based on their unique needs and circumstances.

Is mental health a combined treatment with addiction at this rehab?

At many reputable rehabilitation centers, including Kirkbride Center, mental health treatment is integrated with addiction treatment, as it recognizes the intricate relationship between substance use disorders and mental health conditions. This integrated approach is rooted in scientific evidence demonstrating that addressing co-occurring mental health issues alongside addiction leads to more comprehensive and successful outcomes. By concurrently treating both conditions, patients receive holistic care that targets the underlying factors contributing to their substance use and mental health challenges. Moreover, integrated treatment ensures that individuals learn healthy coping mechanisms and acquire skills to manage their mental health symptoms without resorting to substance use. This approach also reduces the risk of relapse and promotes long-term recovery.

Begin a New Life: Kirkbride Center Inpatient Treatment in Philadelphia, PA

Kirkbride Center offers a wide range of behavioral health services, including detoxification, addiction treatment, and support for co-occurring disorders. Our dedicated team evaluates each individual's strengths and challenges to create a personalized treatment plan. We collaborate with patients to develop a plan for life after discharge, connecting them with community resources for ongoing support. 

Philadelphia, recognized as University City, is not immune to the challenges posed by the addiction crisis. Fentanyl remains the primary drug linked to deaths in Philadelphia, identified in a staggering 96% of cases involving opioids. Moreover, cocaine is prevalent in 88% of stimulant-related fatalities, positioning it as the second most implicated drug in overdoses. Notably, a significant 57% of overdose deaths in Philadelphia involve both opioids like fentanyl and stimulants like cocaine. Xylazine, a veterinary medicine, also appears in 34% of all overdose deaths, with a notable correlation to fentanyl presence in virtually every case where xylazine is detected. [3] These recent data emphasize the critical need for urgent action to address addiction.

Kirkbride Center programs are designed to restore hope and promote recovery. They provide research-based therapies in a supportive environment to meet each patient's needs. However, if you're seeking additional drug rehab centers in Philadelphia, look no further! We're here to guide you in finding the perfect fit for your needs and goals. Let's navigate this together and discover the support and resources you deserve for your path to recovery.

Resources:

[1] Operation Engage Philadelphia - Drug Enforcement Administration (DEA)

[2] McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010 Sep;33(3):511-25. Doi: 10.1016/j.psc.2010.04.012. PMID: 20599130; PMCID: PMC2897895.

[3] Philadelphia Records More than 1,400 Overdose Deaths in 2022; Deaths among Black Residents Rose Nearly 20% -  City of Philadelphia (.gov)